AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Kollmannsberger, C Mayer, F Kuczyk, M Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy, WORLD J URO, 19(2), 2001, pp. 120-125

Authors: Machtens, S Serth, J Bokemeyer, C Bathke, W Minssen, A Kollmannsberger, C Hartmann, J Knuchel, R Kondo, M Jonas, U Kuczyk, M
Citation: S. Machtens et al., Expression of the p53 and maspin protein in primary prostate cancer: Correlation with clinical features, INT J CANC, 95(5), 2001, pp. 337-342

Authors: Kollmannsberger, C Gerl, A Schleucher, N Beyer, J Kuczyk, M Rick, O Gasper, J Sosada, M Rie, C Kanz, L Bokemeyer, C
Citation: C. Kollmannsberger et al., Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer, ANTI-CANC D, 11(7), 2000, pp. 535-539

Authors: Machtens, S Schultheiss, D Kuczyk, M Truss, MC Jonas, U
Citation: S. Machtens et al., The history of endocrine therapy of benign and malignant diseases of the prostate, WORLD J URO, 18(3), 2000, pp. 222-226

Authors: Souchon, R Krege, S Schmoll, HJ Albers, P Beyer, J Bokemeyer, C Classen, J Dieckmann, KP Hartmann, M Heidenreich, A Holtl, W Kliesch, S Kohrmann, KU Kuczyk, M Schmidberger, H Weinknecht, S Winter, E Wittekind, C Bamberg, M
Citation: R. Souchon et al., Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors. Results of an update conference based on evidence-based medicine (EBM), STRAH ONKOL, 176(9), 2000, pp. 388-405

Authors: Kuczyk, M Machtens, S
Citation: M. Kuczyk et S. Machtens, Predictive value of decreased p27 Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients, PROSTATE C, 2, 1999, pp. S17-S17

Authors: Serth, J Kuczyk, M Machtens, S Bokemeyer, C Herrmann, R Hartmann, J Knuchel, R Jonas, U
Citation: J. Serth et al., Analysis of the cyclin-dependent kinase inhibitor p27(Kip1) in muscle invasive bladder cancer, ONCOL REP, 6(1), 1999, pp. 229-233

Authors: Kuczyk, M Serth, J Bokemeyer, C Machtens, S Schwede, J Herrmann, R Paeslack, U Truss, MC Knuchel, R Jonas, U
Citation: M. Kuczyk et al., The need for microdissectional tumor cell preparation during the moleculargenetic analysis of prostate cancer, WORLD J URO, 17(2), 1999, pp. 115-122

Authors: Machtens, S Serth, J Kuczyk, M
Citation: S. Machtens et al., New aspects on genetic alterations and biological prognostic parameters incancer of the prostate, ONKOLOGIE, 22(4), 1999, pp. 322-325

Authors: Heinzer, H Huland, H Kuczyk, M
Citation: H. Heinzer et al., Editorial: Renal cell carcinoma - any new developments?, UROLOGE, 38(5), 1999, pp. 423-424

Authors: Machtens, S Kuczyk, M Becker, AJ Bokemeyer, C Serth, J Jonas, U
Citation: S. Machtens et al., New aspects on the identification of genetic alterations and prognostically important biological parameters in renal cell cancer, UROLOGE, 38(5), 1999, pp. 442-451

Authors: Kuczyk, M Munch, T Machtens, S Wunning, T Grunewald, V Stief, CG Hofner, K Jonas, U
Citation: M. Kuczyk et al., Therapy for kidney cell carcinoma with cava thrombus. Importancy of extracorporeal circulation and prognostic value of cranial tumor extension, UROLOGE, 38(5), 1999, pp. 460-465

Authors: Albers, P Siener, R Hartmann, M Weinknecht, S Schulze, H Rebmann, U Kuczyk, M deRiese, W Loy, V Bierhoff, E Wittekind, C
Citation: P. Albers et al., Risk factors for relapse in stage I non-seminomatous germ-cell tumors: Preliminary results of the German Multicenter Trial, INT J CANC, 83(6), 1999, pp. 828-830

Authors: Kuczyk, M Machtens, S Stief, C Jonas, U
Citation: M. Kuczyk et al., Management of the post-chemotherapy residual mass in patients with advanced stage non-seminomatous germ cell tumors (NSGCT), INT J CANC, 83(6), 1999, pp. 852-855

Authors: Kuczyk, M Machtens, S Hradil, K Schubach, J Christian, W Knuchel, R Hartmann, J Bokemeyer, C Jonas, U Serth, J
Citation: M. Kuczyk et al., Predictive value of decreased p27(Kip1) protein expression for the recurrence-free and long-term survival of prostate cancer patients, BR J CANC, 81(6), 1999, pp. 1052-1058

Authors: Heidenreich, A Kuczyk, M Albers, P
Citation: A. Heidenreich et al., Molecular pathogenesis and molecular prognosis factors of the testicular tumor, UROLOGE, 37(6), 1998, pp. 593

Authors: Machtens, S Kuczyk, M Serth, J Bokemeyer, C Macheel, I Jetscho, I Hradil, K Hermann, R Hartmann, J Thon, WF Jonas, U
Citation: S. Machtens et al., Prognostic significance of cell cycle-associated genes p27(Kipf) and p21(WAF/Cip) for muscle-invasive carcinoma, AKT UROL, 29(7), 1998, pp. 341-348
Risultati: 1-17 |